SHPH: חוב לטווח קצר להון עצמי Shuttle Pharmaceuticals Holdings, Inc.

The price trend visualization for Shuttle Pharmaceuticals (SHPH) helps assess the effectiveness of alliances with clinics to create sensitizers for brain tumor therapy, where the indicator stands at 0.00. The business relies on unique patents, avoiding price wars due to a lack of direct analogs. The company's success is based on the trial results of new molecules and the ability to attract capital for long-term oncology research.

The investment attractiveness of Shuttle Pharmaceuticals (SHPH) is based on the patent protection of radiosensitizers, however, an analysis of the ratio of short-term borrowings to equity allows for an assessment of current liquidity and debt load risk. By examining the dynamics of short-term liabilities to equity, an investor can see the dependence of financial stability on operational loans, where any increase in the coefficient signals potential price volatility despite future FCF growth.